PRESENTERS
KEYNOTE SPEAKERS
Rachel L. Levine, MD
17th U.S. Assistant Secretary for Health
Mary Anne Heino
Chair of the Board
PRESENTERS
G. Arna Sveinsdóttir
Chief Financial Officer
Embla Medical
Ron Cooper
Chief Executive Officer
enGene
Executive Vice President, Chief Financial Officer & Treasurer
Cooper Companies
Brian Andrews
General Manager
Oslo Cancer Cluster
Ketil Widerberg
Sten Sörensen
Chief Executive Officer
Cereno Scientific
Fredrik Tiberg
Chief Executive Officer
Camurus
Chief Financial Officer
Orion
René Lindell
Sarah K. Emond
President & CEO
Institute for Clinical and Economic Review
John A. Urquhart
Senior Managing Director
HRCx
President & Chief Executive Officer
Getinge
Mattias Perjos
Laura Niklason
Founder, President and Chief Executive Officer
Humacyte Global
Chief Financial Officer
BioArctic
Anders Martin-Löf
President & Division Head, Gene Therapy Research & Technical Operations
Astellas Gene Therapies
Morten Sogaard
David Nathan
Director, MGH Clinical Research Center
MGH Harvard
Thomas Holm Pedersen
Chief Executive Officer
NMD Pharma
Head of DNB Corporate Banking, North America
DNB Bank
Thomas Tangen
Chief Financial Officer
XVIVO Perfusion
Kristoffer Nordström
Morten Faester
Director, Corporate Business Development
Pharmacosmos
Vice President, Strategic Finance and Investor Relations
Ironwood Pharmaceuticals
Greg Martini
Michaela Levin
Vice President, Business Development
Recursion Pharma
Vice President of Investor Relations
Lundbeck
Palle Holm Olesen
Director, North American Investor Relations
Novo Nordisk
Frederik Taylor Pitter
President & CEO
Photocure
Dan Schneider
Associate Director, Investment Banking
Back Bay Life Sciences Advisors
Crystal Hsu
Anne Grabe
Global Head of Healthcare Banking
DNB Bank
Vasilios Kofitsas
Partner, Managing Director, Investment Banking
Back Bay Life Sciences Advisors
Ted Jadick
President & CEO
DNB Markets Inc.
Rune Sandager
Head of Investor Relations
GN Group
Gregory Benning
Partner, Managing Director, Head of Investment Banking
Back Bay Life Sciences Advisors
Peter Bak
Partner, Managing Director
Back Bay Life Sciences Advisors
CEO & Managing Partner
Back Bay Life Sciences Advisors
Jonathan Gertler
Andreas Dirnagl
Client Advisor, Healthcare Corporate Banking
DNB Bank
Paul LaViolette
Managing Partner & Chief Operating Officer
SV Health Investors
Peter Legind-Hansen
Global Listings Service Director
Nasdaq Nordic
AVP, Global Listing Nasdaq
Nasdaq Nordic
Carsten Borring
Per Plotnikof
VP, Corporate Communication, Investor Relations and Strategic Planning
ALK-Abelló
Managing Director
Back Bay Life Sciences Advisors
Steve Gauldie
Chief Executive Officer
F2G
Francesco Maria Lavino
Chief Executive Officer
Elekta
Gustaf Salford
Vice President, Global External Innovation, Medical Devices
Johnson&Johnson
Bruce Rosengard
Chief Commercial Officer
Sobi
Bob Jahr
Chief Executive Officer
XVIVO
Christoffer Rosenblad
Chief Executive Officer
BoneSupport
Emil Billbaeck
Director, Head of Investor Relations
Demant
Peter Pudselykke
Senior Research Equity Analyst, Healthcare
DNB Markets Inc.
Jesper Ingildsen
Senior Equity Analyst, Healthcare
DNB Markets Inc.
Rune Majlund Dahl
Senior Healthcare Equity Analyst
DNB Markets Inc.
Patrik Ling
Head of Investor Relations
Elekta
Peter Nyquist
Chief Executive Officer
Adcendo
Michael Pehl
Senior Equity Analyst, Healthcare
DNB Markets Inc.
Geir Hiller Holom
Chief Executive Officer
Nanoform
Edward Hæggström
Head of DNB North America
DNB Bank
Vidar Andersen
Managing Director
DNB Markets Inc.
James Cirenza
Head of Healthcare Investment Banking
Carnegie
Sebastian Alexanderson
TRACK MODERATORS
Vasilios Kofitsas
Partner, Managing Director, Investment Banking
Back Bay Life Sciences Advisors
Andreas Dirnagl
Client Advisor, Healthcare Corporate Banking
DNB Bank
Associate Director, Investment Banking
Back Bay Life Sciences Advisors
Crystal Hsu
Client Advisor, Healthcare
DNB Bank
Devan Patel
